Elisa Morales-Marroquin1,2, Luyu Xie1,2, Luigi Meneghini3,4, Nestor de la Cruz-Muñoz5, Jaime P Almandoz3,4, Sunil M Mathew1,2, Benjamin E Schneider6, Sarah E Messiah1,2. 1. School of Public Health, University of Texas Health Science Center, Dallas, Texas, USA. 2. Center for Pediatric Population Health, UTHealth School of Public Health and Children's Health System of Texas, Dallas, Texas, USA. 3. Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA. 4. Global Diabetes Program, Parkland Health & Hospital System, Dallas, Texas, USA. 5. Department of Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA. 6. Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Abstract
OBJECTIVE: The main goal of this analysis was to determine whether type 2 diabetes and hemoglobin A1c (HbA1c) predict all-cause 30-day hospital readmission after metabolic and bariatric surgery (MBS). It was hypothesized that a diagnosis of type 2 diabetes or high HbA1c values would predict all-cause hospital readmission rates post MBS. METHODS: A retrospective analysis from the 2015-2018 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) cohort was completed (N = 744,776); 30,972 participants were readmitted during the 30 days post MBS. RESULTS: Mean age of the MBSAQIP sample was 45.1 (11.5) years, and the majority were female (80.7%) and non-Hispanic White (59.4%). The all-cause hospital readmission rate was 4.2% and increased by 10% in those with uncontrolled type 2 diabetes (HbA1c > 7.5% [> 58 mmol/mol]); after adjustment, diabetes was not associated with increased readmission. Uncontrolled type 2 diabetes, type 2 diabetes, and prediabetes resulted in less weight loss 30 days post MBS. CONCLUSIONS: These results based on a national MBS cohort showed that uncontrolled type 2 diabetes is associated with a greater likelihood of all-cause hospital readmission and reduced weight loss 30 days post MBS. Both type 2 diabetes and prediabetes were also associated with decreased weight loss 30 days post MBS. These findings highlight the need to classify and optimize glycemic control prior to MBS.
OBJECTIVE: The main goal of this analysis was to determine whether type 2 diabetes and hemoglobin A1c (HbA1c) predict all-cause 30-day hospital readmission after metabolic and bariatric surgery (MBS). It was hypothesized that a diagnosis of type 2 diabetes or high HbA1c values would predict all-cause hospital readmission rates post MBS. METHODS: A retrospective analysis from the 2015-2018 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) cohort was completed (N = 744,776); 30,972 participants were readmitted during the 30 days post MBS. RESULTS: Mean age of the MBSAQIP sample was 45.1 (11.5) years, and the majority were female (80.7%) and non-Hispanic White (59.4%). The all-cause hospital readmission rate was 4.2% and increased by 10% in those with uncontrolled type 2 diabetes (HbA1c > 7.5% [> 58 mmol/mol]); after adjustment, diabetes was not associated with increased readmission. Uncontrolled type 2 diabetes, type 2 diabetes, and prediabetes resulted in less weight loss 30 days post MBS. CONCLUSIONS: These results based on a national MBS cohort showed that uncontrolled type 2 diabetes is associated with a greater likelihood of all-cause hospital readmission and reduced weight loss 30 days post MBS. Both type 2 diabetes and prediabetes were also associated with decreased weight loss 30 days post MBS. These findings highlight the need to classify and optimize glycemic control prior to MBS.
Authors: Alexandra E Butler; Juliette Janson; Susan Bonner-Weir; Robert Ritzel; Robert A Rizza; Peter C Butler Journal: Diabetes Date: 2003-01 Impact factor: 9.461
Authors: Sean Manning; Andrea Pucci; Nicholas C Carter; Mohamed Elkalaawy; Giorgia Querci; Silvia Magno; Anna Tamberi; Nicholas Finer; Alberic G Fiennes; Majid Hashemi; Andrew D Jenkinson; Marco Anselmino; Ferruccio Santini; Marco Adamo; Rachel L Batterham Journal: Surg Endosc Date: 2014-09-20 Impact factor: 4.584
Authors: Yangbo Sun; Buyun Liu; Jessica K Smith; Marcelo L G Correia; Dana L Jones; Zhanyong Zhu; Adeyinka Taiwo; Lisa L Morselli; Katie Robinson; Alexander A Hart; Linda G Snetselaar; Wei Bao Journal: JAMA Netw Open Date: 2020-05-01